<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="concession" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="joint" type="multinuc"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1002" relname="preparation">Stroke is a major cause of dementia , especially in the elderly .</segment>
<segment id="3" parent="1004" relname="span">Specifically , the one-year post-stroke dementia</segment>
<segment id="4" parent="3" relname="restatement">( PSD )</segment>
<segment id="5" parent="1003" relname="same_unit">rates after first-ever and recurrent stroke are approximately 10 % and 30 % , respectively .</segment>
<segment id="6" parent="1007" relname="span">Neuropathological studies into Alzheimer ’s disease</segment>
<segment id="7" parent="6" relname="restatement">( AD )</segment>
<segment id="8" parent="9" relname="attribution">have shown</segment>
<segment id="9" parent="1008" relname="span">that AD pathology is often concomitant with ischemic lesions in the elderly .</segment>
<segment id="10" parent="1012" relname="attribution">For instance , evidence from the Nun Study showed</segment>
<segment id="11" parent="1012" relname="span">that lacunes increase the risk of clinical expression of cognitive impairment more than 20 times during early Braak stages</segment>
<segment id="12" parent="1013" relname="span">that were yet sufficient</segment>
<segment id="13" parent="12" relname="purpose">to produce dementia symptoms .</segment>
<segment id="14" parent="15" relname="attribution">It follows</segment>
<segment id="15" parent="1015" relname="span">that vascular insults enhance the clinical expression of AD pathology .</segment>
<segment id="16" parent="1018" relname="span">Vascular dementia is more prevalent in men and in populations</segment>
<segment id="17" parent="16" relname="elaboration">affected by cerebral small-vessel disease ,</segment>
<segment id="18" parent="1018" relname="elaboration">including Asians , Hispanics , and Africans .</segment>
<segment id="19" parent="1020" relname="span">The cholinergic system is distributed throughout the central nervous system ,</segment>
<segment id="20" parent="1021" relname="joint">playing a role in neurotransmission</segment>
<segment id="21" parent="1021" relname="joint">and possibly mediating various neuroprotective functions .</segment>
<segment id="22" parent="1024" relname="span">Furthermore , cholinergic neurotransmission regulates the immune response during inflammation , in a pathway</segment>
<segment id="23" parent="1025" relname="span">that involves nicotinic acetylcholine receptors</segment>
<segment id="24" parent="23" relname="restatement">( nAChRs )</segment>
<segment id="25" parent="1023" relname="same_unit">and inhibits peripheral cytokine release .</segment>
<segment id="26" parent="1028" relname="span">In particular , the efferent vagus nerve may release acetylcholine</segment>
<segment id="27" parent="26" relname="elaboration">( Ach ) ,</segment>
<segment id="28" parent="1029" relname="joint">which subsequently binds with macrophage receptors</segment>
<segment id="29" parent="1029" relname="joint">and therefore may inhibit the release of inflammatory factors after stroke .</segment>
<segment id="30" parent="1031" relname="span">In addition to inflammation , excitotoxicity and energy failure following cerebral ischemia may also initiate intracellular death pathways and oxidative stress</segment>
<segment id="31" parent="30" relname="restatement">( OS ) .</segment>
<segment id="32" parent="1034" relname="span">The structural and functional changes</segment>
<segment id="33" parent="32" relname="elaboration">caused by OS</segment>
<segment id="34" parent="1033" relname="same_unit">led to cholinergic and other cellular damage .</segment>
<segment id="35" parent="1035" relname="joint">Cholinergic deficit further caused brain atrophy</segment>
<segment id="36" parent="1035" relname="joint">and finally resulted in cognitive impairment .</segment>
<segment id="37" parent="1037" relname="span">Anticholinergic agents have been shown to regulate OS</segment>
<segment id="38" parent="37" relname="elaboration">and alleviate apoptosis .</segment>
<segment id="39" parent="1039" relname="span">Therefore , a key role in the pathogenesis of stroke and dementia may be attributed to OS .</segment>
<segment id="40" parent="1040" relname="span">Cholinergic dysfunction is related to vascular dementia .</segment>
<segment id="41" parent="1042" relname="span">Specifically , Ach levels in the cerebrospinal fluid are up to 49 % lower in patients with small-vessel vascular dementia than in control patients ,</segment>
<segment id="42" parent="41" relname="elaboration">suggesting that cholinergic agents or cholinesterase inhibitors ,</segment>
<segment id="43" parent="1043" relname="same_unit">both of which increase the Ach level ,</segment>
<segment id="44" parent="1044" relname="span">could be used</segment>
<segment id="45" parent="44" relname="purpose">to treat such patients .</segment>
<segment id="46" parent="1047" relname="attribution">One pilot study showed</segment>
<segment id="47" parent="1048" relname="span">that acetylcholinesterase</segment>
<segment id="48" parent="47" relname="restatement">( AChE )</segment>
<segment id="49" parent="1049" relname="span">inhibitor promoted functional recovery in elderly patients with cognitive impairment</segment>
<segment id="50" parent="49" relname="elaboration">who had suffered stroke .</segment>
<segment id="51" parent="1052" relname="concession">In a rat model of chronic ischemic , AChE activity was slightly decreased in the frontal cortex ,</segment>
<segment id="52" parent="1052" relname="span">but muscarinic acetylcholine receptor M1 was gradually depleted in cerebral cortex , striatum and hippocampus</segment>
<segment id="53" parent="52" relname="elaboration">that are involved in cognitive function .</segment>
<segment id="54" parent="1009" relname="joint">In addition , in stroke patients , reduced AChE activity was correlated with lower survival rate .</segment>
<segment id="55" parent="1057" relname="attribution">Taken together ,</segment>
<segment id="56" parent="57" relname="attribution">these results suggest</segment>
<segment id="57" parent="1057" relname="span">that AChE dysfunction is a result of stroke rather than a cause for further neurodegeneration .</segment>
<segment id="58" parent="1056" relname="elaboration">Moreover , AChE inhibitors exert no effect on stroke risk in dementia patients .</segment>
<segment id="59" parent="60" relname="attribution">These observations suggest</segment>
<segment id="60" parent="1059" relname="span">that Ach and AChE function may predict post-stroke neuronal damage .</segment>
<segment id="61" parent="1061" relname="same_unit">To date , only a few blood biomarkers</segment>
<segment id="62" parent="1063" relname="span">for predicting PSD have been examined</segment>
<segment id="63" parent="62" relname="elaboration">( e.g. , D-amino acid oxidase , β-secretase , and inflammation markers ) ,</segment>
<segment id="64" parent="1065" relname="span">and few studies have focused on changes in blood cholinesterase</segment>
<segment id="65" parent="64" relname="restatement">( ChE )</segment>
<segment id="66" parent="1064" relname="same_unit">levels and activity in patients with PSD .</segment>
<segment id="67" parent="1067" relname="span">Since plasma Ach is metabolized by AChE and butylcholinesterase</segment>
<segment id="68" parent="67" relname="elaboration">( BChE ) ,</segment>
<segment id="69" parent="1068" relname="span">the present study examined the functional activities of these two enzymes in a population of patients with chronic ischemic stroke</segment>
<segment id="70" parent="69" relname="elaboration">( IS ) .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1001" relname="span"/>
<group id="1003" type="multinuc" parent="1002" relname="joint"/>
<group id="1004" type="span" parent="1003" relname="same_unit"/>
<group id="1005" type="span" parent="1002" relname="joint"/>
<group id="1006" type="multinuc" parent="1009" relname="background"/>
<group id="1007" type="span" parent="1006" relname="same_unit"/>
<group id="1008" type="span" parent="1006" relname="same_unit"/>
<group id="1009" type="multinuc" parent="1005" relname="span"/>
<group id="1010" type="span" parent="1009" relname="joint"/>
<group id="1011" type="span" parent="1010" relname="span"/>
<group id="1012" type="span" parent="1011" relname="span"/>
<group id="1013" type="span" parent="11" relname="elaboration"/>
<group id="1014" type="multinuc" parent="1011" relname="elaboration"/>
<group id="1015" type="span" parent="1014" relname="joint"/>
<group id="1016" type="multinuc" parent="1014" relname="joint"/>
<group id="1017" type="span" parent="1016" relname="joint"/>
<group id="1018" type="span" parent="1017" relname="span"/>
<group id="1019" type="multinuc" parent="1016" relname="joint"/>
<group id="1020" type="span" parent="1019" relname="sequence"/>
<group id="1021" type="multinuc" parent="19" relname="elaboration"/>
<group id="1022" type="span" parent="1019" relname="sequence"/>
<group id="1023" type="multinuc" parent="1022" relname="span"/>
<group id="1024" type="span" parent="1023" relname="same_unit"/>
<group id="1025" type="span" parent="22" relname="elaboration"/>
<group id="1026" type="multinuc" parent="1023" relname="elaboration"/>
<group id="1027" type="span" parent="1026" relname="joint"/>
<group id="1028" type="span" parent="1027" relname="span"/>
<group id="1029" type="multinuc" parent="1028" relname="elaboration"/>
<group id="1030" type="multinuc" parent="1026" relname="joint"/>
<group id="1031" type="span" parent="1030" relname="joint"/>
<group id="1032" type="span" parent="1030" relname="joint"/>
<group id="1033" type="multinuc" parent="1032" relname="span"/>
<group id="1034" type="span" parent="1033" relname="same_unit"/>
<group id="1035" type="multinuc" parent="1033" relname="elaboration"/>
<group id="1037" type="span" parent="1009" relname="joint"/>
<group id="1039" type="span" parent="1009" relname="joint"/>
<group id="1040" type="span" parent="39" relname="elaboration"/>
<group id="1041" type="multinuc" parent="40" relname="elaboration"/>
<group id="1042" type="span" parent="1041" relname="same_unit"/>
<group id="1043" type="multinuc" parent="1041" relname="same_unit"/>
<group id="1044" type="span" parent="1043" relname="same_unit"/>
<group id="1046" type="span" parent="1009" relname="joint"/>
<group id="1047" type="multinuc" parent="1046" relname="span"/>
<group id="1048" type="span" parent="1047" relname="same_unit"/>
<group id="1049" type="span" parent="1047" relname="same_unit"/>
<group id="1051" type="span" parent="1009" relname="joint"/>
<group id="1052" type="span" parent="1051" relname="span"/>
<group id="1055" type="span" parent="1009" relname="joint"/>
<group id="1056" type="span" parent="1055" relname="span"/>
<group id="1057" type="span" parent="1056" relname="span"/>
<group id="1058" type="span" parent="1009" relname="joint"/>
<group id="1059" type="span" parent="1058" relname="span"/>
<group id="1060" type="multinuc" parent="1059" relname="elaboration"/>
<group id="1061" type="multinuc" parent="1060" relname="joint"/>
<group id="1062" type="multinuc" parent="1061" relname="same_unit"/>
<group id="1063" type="span" parent="1062" relname="joint"/>
<group id="1064" type="multinuc" parent="1062" relname="joint"/>
<group id="1065" type="span" parent="1064" relname="same_unit"/>
<group id="1066" type="multinuc" parent="1060" relname="joint"/>
<group id="1067" type="span" parent="1066" relname="same_unit"/>
<group id="1068" type="span" parent="1066" relname="same_unit"/>
	</body>
</rst>
